Typ: |
Jednokolová |
Datum otevření: |
24.06.2026 |
Datum uzavření: |
16.09.2026 |
Znalostní a inovační společenství EIT v oblast zdraví (EIT Health) otevřelo dvě výzvy se shodnou uzávěrkou 16. září 2026. Jedná se o Innovation Uptake Call a Transformative Healthcare Instrument 2026. Záznam z webinářů k oběma výzvám z 15. července 2026 je ZDE.
Innovation Uptake Call
EIT Health is calling for mature digital, data-driven and AI-powered healthcare solutions ready to scale across European markets. Selected projects will receive funding to accelerate market entry, generate real-world evidence, strengthen market access, and support the adoption of clinically validated innovations across healthcare systems.
Consortia of at least two independent legal entities from different countries must include partners from at least two sides of the Knowledge Triangle (Industry, Research, Education) and led by a Commercialising Entity (SME or industry player) responsible for bringing the solution to market. Applicants must be legal entities (individuals cannot apply) and only entities established in eligible HE countries (EU Member States, associated countries, or eligible third countries) can apply.
Total call budget is €5.2 milli on and up to 8 projects will be funded. Maximum funding per project is €650 000. Funding covers up to 50% of total project costs (co-funding required).
Key dates
Call opens on: 24 June 2026
Call closes on: 16 September 2026
Open Q&A Session: 01 September 2026 – 11:00 CET – Register here
The call web page is here and the call information and supporting documents are now available to help applicants prepare their proposals.
Transformative Healthcare Instrument 2026
EIT Health is offering between €300 000 and €500 000 in funding to support high-potential European start-ups (specifically Micro, Small and Medium-sized enterprises with at least 4 FTE employees) developing innovative solutions in biotech, medtech, digital health, AI, and biomarkers or diagnostics.
Eligible companies must have closed a minimum total equity investment of 2,000,000 EUR within the previous 36-months, with at least one new investor contributing.
The programme is designed to help companies advance product development, strengthen commercialisation strategies, and prepare for their next stage of fundraising while addressing unmet clinical needs across Europe. EIT Health will fund a maximum of 50% of the project’s total costs. The company must secure the remaining 50% co-funding from other sources.
Key Dates
Call opens on: 24 June 2026
Call closes on: 16 September 2026
Open Q&A Session: 02 September 2026 – 11:00 CET – Register here
The call web page and the call information and supporting documents are now available to help applicants prepare their proposals.